Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

How might neighborhood built environment influence child maltreatment? Caregiver perceptions.

Haas BM, Berg KA, Schmidt-Sane MM, Korbin JE, Spilsbury JC.

Soc Sci Med. 2018 Oct;214:171-178. doi: 10.1016/j.socscimed.2018.08.033. Epub 2018 Aug 27.

PMID:
30177363
2.

Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.

Berg KA, Clarke WP.

Int J Neuropsychopharmacol. 2018 Oct 1;21(10):962-977. doi: 10.1093/ijnp/pyy071.

3.

Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy.

Jacobs BA, Pando MM, Jennings E, Chavera TA, Clarke WP, Berg KA.

Mol Pharmacol. 2018 Apr;93(4):376-386. doi: 10.1124/mol.117.109975. Epub 2018 Feb 7.

PMID:
29436492
4.

Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy.

LoCoco PM, Risinger AL, Smith HR, Chavera TS, Berg KA, Clarke WP.

Elife. 2017 Nov 10;6. pii: e29626. doi: 10.7554/eLife.29626.

5.

Promoting the development of resilient academic functioning in maltreated children.

Holmes MR, Yoon S, Berg KA, Cage JL, Perzynski AT.

Child Abuse Negl. 2018 Jan;75:92-103. doi: 10.1016/j.chiabu.2017.07.018. Epub 2017 Aug 4.

PMID:
28784310
6.

Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.

Sullivan LC, Chavera TA, Gao X, Pando MM, Berg KA.

J Pharmacol Exp Ther. 2017 Jul;362(1):200-209. doi: 10.1124/jpet.117.241604. Epub 2017 May 2.

7.

Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101.

Higgins GA, Silenieks LB, Patrick A, De Lannoy IAM, Fletcher PJ, Parker LA, MacLusky NJ, Sullivan LC, Chavera TA, Berg KA.

ACS Chem Neurosci. 2017 May 17;8(5):1074-1084. doi: 10.1021/acschemneuro.6b00444. Epub 2017 Mar 24.

PMID:
28338324
8.

Maternal depression and intimate partner violence exposure: Longitudinal analyses of the development of aggressive behavior in an at-risk sample.

Holmes MR, Yoon S, Berg KA.

Aggress Behav. 2017 Jul;43(4):375-385. doi: 10.1002/ab.21696. Epub 2017 Jan 27.

PMID:
28127778
9.

Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Sullivan LC, Chavera TS, Jamshidi RJ, Berg KA, Clarke WP.

J Pharmacol Exp Ther. 2016 Dec;359(3):411-419. Epub 2016 Sep 22.

10.
11.

Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.

Jamshidi RJ, Jacobs BA, Sullivan LC, Chavera TA, Saylor RM, Prisinzano TE, Clarke WP, Berg KA.

J Pharmacol Exp Ther. 2015 Nov;355(2):174-82. doi: 10.1124/jpet.115.225896. Epub 2015 Aug 21.

12.

Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

Sullivan LC, Clarke WP, Berg KA.

Curr Pharm Des. 2015;21(26):3732-8.

13.

Divergence in endothelin-1- and bradykinin-activated store-operated calcium entry in afferent sensory neurons.

Szteyn K, Gomez R, Berg KA, Jeske NA.

ASN Neuro. 2015 Apr 13;7(2). pii: 1759091415578714. doi: 10.1177/1759091415578714. Print 2015 Mar-Apr.

14.

Dual regulation of δ-opioid receptor function by arachidonic acid metabolites in rat peripheral sensory neurons.

Sullivan LC, Berg KA, Clarke WP.

J Pharmacol Exp Ther. 2015 Apr;353(1):44-51. doi: 10.1124/jpet.114.221366. Epub 2015 Jan 30.

15.

Interleukin-6 attenuates serotonin 2a receptor signaling by activating the JAK-STAT pathway.

Donegan JJ, Patton MS, Chavera TS, Berg KA, Morilak DA, Girotti M.

Mol Pharmacol. 2015;87(3):492-500. doi: 10.1124/mol.114.096289. Epub 2014 Dec 30.

16.

AGR2, an endoplasmic reticulum protein, is secreted into the gastrointestinal mucus.

Bergström JH, Berg KA, Rodríguez-Piñeiro AM, Stecher B, Johansson ME, Hansson GC.

PLoS One. 2014 Aug 11;9(8):e104186. doi: 10.1371/journal.pone.0104186. eCollection 2014.

17.

G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production.

Broselid S, Berg KA, Chavera TA, Kahn R, Clarke WP, Olde B, Leeb-Lundberg LM.

J Biol Chem. 2014 Aug 8;289(32):22117-27. doi: 10.1074/jbc.M114.566893. Epub 2014 Jun 24.

18.

Activation of estrogen receptor α enhances bradykinin signaling in peripheral sensory neurons of female rats.

Rowan MP, Berg KA, Roberts JL, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2014 Jun;349(3):526-32. doi: 10.1124/jpet.114.212977. Epub 2014 Apr 4.

19.

Signalling profile differences: paliperidone versus risperidone.

Clarke WP, Chavera TA, Silva M, Sullivan LC, Berg KA.

Br J Pharmacol. 2013 Oct;170(3):532-45. doi: 10.1111/bph.12295.

20.

β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel.

Por ED, Bierbower SM, Berg KA, Gomez R, Akopian AN, Wetsel WC, Jeske NA.

J Biol Chem. 2012 Oct 26;287(44):37552-63. doi: 10.1074/jbc.M112.391847. Epub 2012 Sep 5.

21.

Receptor and channel heteromers as pain targets.

Berg KA, Patwardhan AM, Akopian AN.

Pharmaceuticals (Basel). 2012 Feb 23;5(3):249-78. doi: 10.3390/ph5030249.

22.

Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.

Berg KA, Rowan MP, Gupta A, Sanchez TA, Silva M, Gomes I, McGuire BA, Portoghese PS, Hargreaves KM, Devi LA, Clarke WP.

Mol Pharmacol. 2012 Feb;81(2):264-72. doi: 10.1124/mol.111.072702. Epub 2011 Nov 9.

23.

Virulence genes of Aeromonas isolates, bacterial endotoxins and cyanobacterial toxins from recreational water samples associated with human health symptoms.

Berg KA, Lyra C, Niemi RM, Heens B, Hoppu K, Erkomaa K, Sivonen K, Rapala J.

J Water Health. 2011 Dec;9(4):670-9. doi: 10.2166/wh.2011.206.

PMID:
22048427
24.

Barriers to pediatric pain management: a nursing perspective.

Czarnecki ML, Simon K, Thompson JJ, Armus CL, Hanson TC, Berg KA, Petrie JL, Xiang Q, Malin S.

Pain Manag Nurs. 2011 Sep;12(3):154-62. doi: 10.1016/j.pmn.2010.07.001. Epub 2010 Sep 9.

PMID:
21893304
25.

A-kinase anchoring protein 150 mediates transient receptor potential family V type 1 sensitivity to phosphatidylinositol-4,5-bisphosphate.

Jeske NA, Por ED, Belugin S, Chaudhury S, Berg KA, Akopian AN, Henry MA, Gomez R.

J Neurosci. 2011 Jun 8;31(23):8681-8. doi: 10.1523/JNEUROSCI.0020-11.2011.

26.

Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.

Berg KA, Rowan MP, Sanchez TA, Silva M, Patwardhan AM, Milam SB, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2011 Jul;338(1):92-9. doi: 10.1124/jpet.110.177493. Epub 2011 Apr 12.

27.

Metallopeptidase inhibition potentiates bradykinin-induced hyperalgesia.

Gomez R, Por ED, Berg KA, Clarke WP, Glucksman MJ, Jeske NA.

Pain. 2011 Jul;152(7):1548-54. doi: 10.1016/j.pain.2011.02.044. Epub 2011 Apr 1.

28.

Inverse agonism at serotonin and cannabinoid receptors.

Aloyo VJ, Berg KA, Clarke WP, Spampinato U, Harvey JA.

Prog Mol Biol Transl Sci. 2010;91:1-40. doi: 10.1016/S1877-1173(10)91001-6. Review.

PMID:
20691957
29.

17beta-estradiol rapidly enhances bradykinin signaling in primary sensory neurons in vitro and in vivo.

Rowan MP, Berg KA, Milam SB, Jeske NA, Roberts JL, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2010 Oct;335(1):190-6. doi: 10.1124/jpet.110.167445. Epub 2010 Jul 20.

30.

Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimers.

Brea J, Castro M, Giraldo J, López-Giménez JF, Padín JF, Quintián F, Cadavid MI, Vilaró MT, Mengod G, Berg KA, Clarke WP, Vilardaga JP, Milligan G, Loza MI.

Mol Pharmacol. 2009 Jun;75(6):1380-91. doi: 10.1124/mol.108.054395. Epub 2009 Mar 11.

31.

Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.

Aloyo VJ, Berg KA, Spampinato U, Clarke WP, Harvey JA.

Pharmacol Ther. 2009 Feb;121(2):160-73. doi: 10.1016/j.pharmthera.2008.10.010. Epub 2008 Dec 6. Review.

PMID:
19109993
32.

Peripheral delta opioid receptors require priming for functional competence in vivo.

Rowan MP, Ruparel NB, Patwardhan AM, Berg KA, Clarke WP, Hargreaves KM.

Eur J Pharmacol. 2009 Jan 14;602(2-3):283-7. doi: 10.1016/j.ejphar.2008.11.028. Epub 2008 Nov 25.

33.

High diversity of cultivable heterotrophic bacteria in association with cyanobacterial water blooms.

Berg KA, Lyra C, Sivonen K, Paulin L, Suomalainen S, Tuomi P, Rapala J.

ISME J. 2009 Mar;3(3):314-25. doi: 10.1038/ismej.2008.110. Epub 2008 Nov 20.

PMID:
19020559
34.

Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.

Berg KA, Harvey JA, Spampinato U, Clarke WP.

Prog Brain Res. 2008;172:287-305. doi: 10.1016/S0079-6123(08)00914-X. Review.

PMID:
18772038
35.

Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.

Berg KA, Clarke WP, Cunningham KA, Spampinato U.

Neuropharmacology. 2008 Nov;55(6):969-76. doi: 10.1016/j.neuropharm.2008.06.014. Epub 2008 Jun 17. Review.

36.

Surgery with cooperative robots.

Lehman AC, Berg KA, Dumpert J, Wood NA, Visty AQ, Rentschler ME, Platt SR, Farritor SM, Oleynikov D.

Comput Aided Surg. 2008 Mar;13(2):95-105. doi: 10.3109/10929080801956706.

PMID:
18317958
37.
38.

Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.

Berg KA, Patwardhan AM, Sanchez TA, Silva YM, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2007 Jun;321(3):839-47. Epub 2007 Mar 8.

39.

Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.

Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP.

J Pharmacol Exp Ther. 2007 Jun;321(3):1054-61. Epub 2007 Mar 2.

40.

Integrins regulate opioid receptor signaling in trigeminal ganglion neurons.

Berg KA, Zardeneta G, Hargreaves KM, Clarke WP, Milam SB.

Neuroscience. 2007 Feb 9;144(3):889-97. Epub 2006 Dec 8.

41.

First observation of cylindrospermopsin in Anabaena lapponica isolated from the boreal environment (Finland).

Spoof L, Berg KA, Rapala J, Lahti K, Lepistö L, Metcalf JS, Codd GA, Meriluoto J.

Environ Toxicol. 2006 Dec;21(6):552-60.

PMID:
17091499
42.

Removal of cyanobacteria, cyanotoxins, heterotrophic bacteria and endotoxins at an operating surface water treatment plant.

Rapala J, Niemelä M, Berg KA, Lepistö L, Lahti K.

Water Sci Technol. 2006;54(3):23-8.

PMID:
17037128
43.

Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses.

Berg KA, Navailles S, Sanchez TA, Silva YM, Wood MD, Spampinato U, Clarke WP.

J Pharmacol Exp Ther. 2006 Oct;319(1):260-8. Epub 2006 Jun 28.

44.

PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor.

Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, Hargreaves KM.

Pain. 2006 Nov;125(1-2):114-24. Epub 2006 Jun 14.

PMID:
16781076
45.

Modulation of bradykinin signaling by EP24.15 and EP24.16 in cultured trigeminal ganglia.

Jeske NA, Berg KA, Cousins JC, Ferro ES, Clarke WP, Glucksman MJ, Roberts JL.

J Neurochem. 2006 Apr;97(1):13-21. Epub 2006 Mar 3.

46.

Artificial insemination with frozen semen in dogs: a retrospective study of 10 years using a non-surgical approach.

Thomassen R, Sanson G, Krogenaes A, Fougner JA, Berg KA, Farstad W.

Theriogenology. 2006 Oct;66(6-7):1645-50. Epub 2006 Feb 15.

PMID:
16469370
47.

Dynamic expression of the prion-like protein Doppel in ovine testicular tissue.

Espenes A, Harbitz I, Skogtvedt S, Fuglestveit R, Berg KA, Dick G, Krogenaes A, Tranulis MA.

Int J Androl. 2006 Jun;29(3):400-8. Epub 2005 Dec 22.

PMID:
16390495
48.

Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors.

Berg KA, Harvey JA, Spampinato U, Clarke WP.

Trends Pharmacol Sci. 2005 Dec;26(12):625-30. Epub 2005 Nov 2. Review.

PMID:
16269190
49.

Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors.

Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, Hargreaves KM.

J Neurosci. 2005 Sep 28;25(39):8825-32.

50.

Paucibacter toxinivorans gen. nov., sp. nov., a bacterium that degrades cyclic cyanobacterial hepatotoxins microcystins and nodularin.

Rapala J, Berg KA, Lyra C, Niemi RM, Manz W, Suomalainen S, Paulin L, Lahti K.

Int J Syst Evol Microbiol. 2005 Jul;55(Pt 4):1563-8.

PMID:
16014482

Supplemental Content

Support Center